- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Strategies to Optimize Patient Outcomes in Bipolar I Disorder
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Strategies to Optimize Patient Outcomes in Bipolar I Disorder
In this presentation, the objectives are to:
- Understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes
- Discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder
- Review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder
Featuring
Samantha Canto, PharmD
Dante Durand, MD, MBA
Vice Chair of Clinical Services & Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine; Chief Medical Officer at Jackson Behavioral Health Hospital in Miami, FL.
MoreDr. Dante Durand is an Associate Professor and the Vice-Chair of Clinical Services for the Department of Psychiatry at the University of Miami Miller School of Medicine. He is also the Chief Medical Officer at Jackson Behavioral Health Hospital. Dr. Durand’s area of clinical and research interest is schizophrenia. He has written several scientific articles and is the principal investigator on multiple clinical trials in this area. As faculty member, Dr. Durand has been involved in the education of future generation of psychiatrists and due to his teaching abilities, he has received multiple honors such as the University of Miami, Department of Psychiatry Senior Teaching Award for 5 consecutive years. Dr. Durand is a fellow of the American Psychiatric Association, a member of the American College of Psychiatrists and a board examiner of the American Board of Psychiatry and Neurology.Samantha Canto, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Dante Durand, MD, MBA is a speaker for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
Virtual Event – Addressing Unresolved Symptoms of Major Depressive Disorder
December 5 12:00 pm to 1:00 pm -
Virtual Event – Unmet Needs in Agitation Associated with Dementia Due to Alzheimer’s Disease
December 10 3:00 pm to 4:00 pm -
Virtual Event – Addressing Unresolved Symptoms of Major Depressive Disorder
December 17 12:00 pm to 1:00 pm
Registration
Log in to register
Related Resources
-
Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)
On-Demand Webinar December 3, 2025In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.
-
Myths & Misconceptions: Bipolar Disorder
Podcast November 10, 2025Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.
-
Understanding the Complexity of Attention-Deficit Hyperactivity Disorder
On-Demand Webinar October 16, 2025Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected:


